Here it comes....the role of cost-effective analysis

Gynecol Oncol. 2012 Nov;127(2):265-6. doi: 10.1016/j.ygyno.2012.09.011.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chemoradiotherapy / economics*
  • Cisplatin / therapeutic use*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Gemcitabine
  • Humans
  • Uterine Cervical Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Cisplatin
  • Gemcitabine